Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis

BACKGROUND: The role of fibroblast growth factor 21 (FGF21) in predicting the long-term prognosis of patients with cardiovascular disease (CVD) remains unknown. METHODS: A comprehensive search in PubMed, Embase, and the Cochrane Library was performed to identify studies reporting the association bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Bing, Ma, Sicong, Yan, Chenghui, Han, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011636/
https://www.ncbi.nlm.nih.gov/pubmed/36926038
http://dx.doi.org/10.3389/fendo.2023.1108234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011636/
https://www.ncbi.nlm.nih.gov/pubmed/36926038
http://dx.doi.org/10.3389/fendo.2023.1108234

Ejemplares similares